Search Results

Phoenix Children’s, one of the nation’s fastest-growing pediatric health systems, announced today that Jared Muenzer, MD, MBA, Chief Physician Executive of the system and Chief Operating Officer for Phoenix Children’s Medical Group, was named one of Modern Healthcare’s 50 Most Influential Clinical Executives for 2024. This prestigious program honors licensed clinicians in executive roles who are paving the way to better health through their executive responsibility, leadership qualities, innovation, community service and achievements inside and outside of their respective organizations.

Phoenix Children’s Medical Group is pleased to welcome nine new providers to its nationally ranked Neonatology program. These providers will serve Phoenix’s growing East Valley and expand the enterprise’s top-ranked neonatology services across Phoenix. Ranked among the top 20 neonatology programs in the United States, Phoenix Children’s NICU and neonatology services support dozens of conditions that impact newborns.

Cynthia Wetmore, MD, PhD, has joined the Center for Cancer and Blood Disorders at Phoenix Children’s as division chief. Dr. Wetmore earned her Bachelor of Arts magna cum laude in history of science from Harvard University, Medical Degree from the University of Minnesota Medical School, and Doctorate in neurobiology from the Karolinska Institute in Stockholm, Sweden. She completed her residency training in pediatrics at the University of Minnesota and Mayo Clinic and completed fellowship training in hematology/oncology and neuro-oncology at St. Jude Children’s Research Hospital.

The Phoenix Tourette Syndrome program is a unique partnership between Phoenix Children’s and Banner Sun Health Research Institute. It first earned its Tourette Association of America (TAA) center of excellence designation in 2020.

Dr. Hauptman, who assumes his post in June, is a highly regarded pediatric neurosurgeon, researcher and professor. A practicing surgeon for more than 10 years, Dr. Hauptman offers unique expertise in the surgical management of pediatric epilepsy, removal of tumors in eloquent brain regions and treatment of congenital brain and spine anomalies in infants and young children.